155 related articles for article (PubMed ID: 11380836)
1. Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo.
Hung KY; Shyu RS; Fang CC; Tsai CC; Lee PH; Tsai TJ; Hsieh BS
Kidney Int; 2001 Jun; 59(6):2316-24. PubMed ID: 11380836
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation.
Hung KY; Chen CT; Yen CJ; Lee PH; Tsai TJ; Hsieh BS
Kidney Int; 2001 Sep; 60(3):872-81. PubMed ID: 11532082
[TBL] [Abstract][Full Text] [Related]
3. Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells.
Hung KY; Chen CT; Huang JW; Lee PH; Tsai TJ; Hsieh BS
Kidney Int; 2001 Oct; 60(4):1249-57. PubMed ID: 11576339
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-beta.
Fang CC; Yen CJ; Chen YM; Shyu RS; Tsai TJ; Lee PH; Hsieh BS
Kidney Int; 2000 Jun; 57(6):2626-33. PubMed ID: 10844633
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
Chen YM; Wu KD; Tsai TJ; Hsieh BS
J Mol Cell Cardiol; 1999 Apr; 31(4):773-83. PubMed ID: 10329205
[TBL] [Abstract][Full Text] [Related]
6. Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fibrosis.
Fang CC; Lai MN; Chien CT; Hung KY; Tsai CC; Tsai TJ; Hsieh BS
Perit Dial Int; 2003; 23(3):228-36. PubMed ID: 12938822
[TBL] [Abstract][Full Text] [Related]
7. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation.
Perfumo F; Altieri P; Degl'Innocenti ML; Ghiggeri GM; Caridi G; Trivelli A; Gusmano R
Nephrol Dial Transplant; 1996 Sep; 11(9):1803-9. PubMed ID: 8918626
[TBL] [Abstract][Full Text] [Related]
8. Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis.
Fang CC; Yen CJ; Chen YM; Ko FN; Tsai TJ; Lee PH; Hsieh BS
Nephrol Dial Transplant; 1996 Nov; 11(11):2276-81. PubMed ID: 8941590
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
10. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
11. Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF-beta1 production on human peritoneal mesothelial cells.
Fang CC; Yen CJ; Chen YM; Chu TS; Lin MT; Yang JY; Tsai TJ
Nephrol Dial Transplant; 2006 May; 21(5):1340-7. PubMed ID: 16421162
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
[TBL] [Abstract][Full Text] [Related]
13. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
Davenport A; Fernando RL; Varghese Z
Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model.
Kato H; Mizuno T; Mizuno M; Sawai A; Suzuki Y; Kinashi H; Nagura F; Maruyama S; Noda Y; Yamada K; Matsuo S; Ito Y
Nephrol Dial Transplant; 2012 Feb; 27(2):526-36. PubMed ID: 21669883
[TBL] [Abstract][Full Text] [Related]
16. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
17. Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells.
Einbinder T; Sufaro Y; Yusim I; Byk G; Passlick-Deetjen J; Chaimovitz C; Douvdevani A
Kidney Int; 2003 Jun; 63(6):2103-12. PubMed ID: 12753297
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Haslinger B; Kleemann R; Toet KH; Kooistra T
Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
[TBL] [Abstract][Full Text] [Related]
19. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
20. Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells.
Chan TM; Leung JK; Tsang RC; Liu ZH; Li LS; Yung S
Kidney Int; 2003 Aug; 64(2):519-33. PubMed ID: 12846747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
